Fortis Life Sciences Acquires nanoComposix
July 23, 2021
Fortis Life Sciences has completed its acquisition of nanoComposix, a premiere nanomaterials company focused on solutions for assay development and diagnostics. Since 2004, nanoComposix has built one of the most comprehensive nanomaterials portfolios in the industry. nanoComposix’s nanomaterials are used in a wide array of Life Sciences applications, including drug delivery, diagnostics and imaging, as well as industrial applications.
Fortis Life Sciences Acquires Bethyl Laboratories
March 10, 2021
Fortis Life Sciences, a life sciences company offering products and solutions for the life sciences industry, has acquired the premium antibody company Bethyl Laboratories. Based in Montgomery, Texas, Bethyl Laboratories has a long history of offering the highest quality primary and secondary antibodies to its customers, as well as other protein detection reagents. Bethyl Laboratories is well known for industry leading performance and the highest standards in antibody validation, and prior to the acquisition by Fortis, had successfully operated as a private, family-owned, and operated business for nearly 50 years.
Biocare Medical and Bethyl Laboratories Announces the Launch of TIGIT IVD Rabbit Monoclonal Antibody for Immunohistochemical Applications
Biocare Medical - August 4, 2020
Biocare Medical and Bethyl Laboratories Announce Strategic Partnership for Antibody Development
Biocare Medical - June 29, 2020
New Collaboration with Bethyl Laboratories Expands Antibody Offerings for Hyperion Imaging System
Fluidigm - June 17, 2020